volume 79 issue 12 pages 2764-2773

Attenuated Sympathetic Blood Pressure Transduction in Patients With Treated Heart Failure With Reduced Ejection Fraction

Publication typeJournal Article
Publication date2022-10-14
scimago Q1
wos Q1
SJR2.788
CiteScore13.1
Impact factor8.2
ISSN0194911X, 15244563, 23071095, 22241485
Internal Medicine
Abstract
Background:

Heart failure with reduced ejection fraction (HFrEF) is associated with reduced cardiac β-adrenergic signal transduction in response to chronic elevations in neurally released and circulating norepinephrine. Whether elevations in muscle sympathetic nerve activity (MSNA) are accompanied by attenuated α-adrenoceptor–mediated vasoconstriction remains unclear. Therefore, the objective of the current work was to compare transduction of sympathetic firing into blood pressure (BP) in treated patients with HFrEF and healthy controls.

Methods:

Twenty-three treated patients with HFrEF (4 females, left ventricular ejection fraction: 28±2%) and 22 healthy controls (6 females) underwent a 7-minute resting measurement of continuous beat-to-beat BP (finger photoplethysmography), heart rate (electrocardiography), and MSNA (microneurography). Sympathetic-BP transduction was quantified using both signal averaging, whereby the BP response to each MSNA burst was serially tracked over 15 cardiac cycles and averaged to derive the peak change in BP, and cross-spectral analysis of low-frequency (0.04–0.15 Hz) MSNA and BP oscillations.

Results:

Compared with controls, patients with HFrEF had less sympathetic-BP transduction (0.7±0.3 versus 0.2±0.3 mm Hg; P <0.01), and lower low-frequency oscillations in MSNA (120±56 versus 64±32 arbitrary units 2 ; P <0.01) and BP (3.1±1.6 versus 2.0±1.7 mm Hg 2 ; P <0.01). In subgroup analysis, resting sympathetic-BP transduction was lower in patients with HFrEF with normal resting MSNA compared to healthy controls (0.7±0.3 versus 0.4±0.3 mm Hg; P =0.01) and further attenuated (0.1±0.1 mm Hg; P =0.03) in patients with HFrEF with elevated resting MSNA.

Conclusions:

Treated HFrEF is associated with lower sympathetic-BP transduction, even when MSNA is not elevated, and diminishes further with disease progression. These adaptations may serve to limit the adverse consequences of oscillatory surges in sympathetic vasoconstrictor discharge on stroke volume.

Found 
Found 

Top-30

Journals

1
2
3
Clinical Autonomic Research
3 publications, 21.43%
American Journal of Physiology - Heart and Circulatory Physiology
2 publications, 14.29%
Journal of Physiology
2 publications, 14.29%
Journal of Applied Physiology
2 publications, 14.29%
Autonomic Neuroscience: Basic and Clinical
2 publications, 14.29%
Experimental Physiology
1 publication, 7.14%
Hypertension
1 publication, 7.14%
Annals of Medicine
1 publication, 7.14%
1
2
3

Publishers

1
2
3
4
American Physiological Society
4 publications, 28.57%
Springer Nature
3 publications, 21.43%
Wiley
3 publications, 21.43%
Elsevier
2 publications, 14.29%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 7.14%
Taylor & Francis
1 publication, 7.14%
1
2
3
4
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
14
Share
Cite this
GOST |
Cite this
GOST Copy
Nardone M. et al. Attenuated Sympathetic Blood Pressure Transduction in Patients With Treated Heart Failure With Reduced Ejection Fraction // Hypertension. 2022. Vol. 79. No. 12. pp. 2764-2773.
GOST all authors (up to 50) Copy
Nardone M., NOTARIUS C. F., Badrov M. B., Millar P. J., Floras J. S. Attenuated Sympathetic Blood Pressure Transduction in Patients With Treated Heart Failure With Reduced Ejection Fraction // Hypertension. 2022. Vol. 79. No. 12. pp. 2764-2773.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1161/hypertensionaha.122.19850
UR - https://doi.org/10.1161/hypertensionaha.122.19850
TI - Attenuated Sympathetic Blood Pressure Transduction in Patients With Treated Heart Failure With Reduced Ejection Fraction
T2 - Hypertension
AU - Nardone, Massimo
AU - NOTARIUS, CATHERINE F.
AU - Badrov, Mark B.
AU - Millar, Philip J.
AU - Floras, John S
PY - 2022
DA - 2022/10/14
PB - Ovid Technologies (Wolters Kluwer Health)
SP - 2764-2773
IS - 12
VL - 79
PMID - 36252088
SN - 0194-911X
SN - 1524-4563
SN - 2307-1095
SN - 2224-1485
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Nardone,
author = {Massimo Nardone and CATHERINE F. NOTARIUS and Mark B. Badrov and Philip J. Millar and John S Floras},
title = {Attenuated Sympathetic Blood Pressure Transduction in Patients With Treated Heart Failure With Reduced Ejection Fraction},
journal = {Hypertension},
year = {2022},
volume = {79},
publisher = {Ovid Technologies (Wolters Kluwer Health)},
month = {oct},
url = {https://doi.org/10.1161/hypertensionaha.122.19850},
number = {12},
pages = {2764--2773},
doi = {10.1161/hypertensionaha.122.19850}
}
MLA
Cite this
MLA Copy
Nardone, Massimo, et al. “Attenuated Sympathetic Blood Pressure Transduction in Patients With Treated Heart Failure With Reduced Ejection Fraction.” Hypertension, vol. 79, no. 12, Oct. 2022, pp. 2764-2773. https://doi.org/10.1161/hypertensionaha.122.19850.